Ledger Weighs $4 Billion U.S. IPO
Cryptocurrency wallet company Ledger is exploring a U.S. public listing that could value the firm at about $4 billion, The Financial Times reported Jan. 23.
Founded in 2015, Ledger bills itself as a cutting-edge platform used by millions of individuals and hundreds of enterprises. The company has reportedly engaged Goldman Sachs and is said to be working alongside Jefferies and Barclays, with plans to list on the New York Stock Exchange later this year.
Merck Walks Away From $30 Billion Biotech Talks
Pharmaceutical heavyweight Merck has stepped back from negotiations to acquire Revolution Medicines Inc., a cancer-focused biotech firm, according to a Sunday report from The Wall Street Journal.
The talks centered on a deal that would have valued Revolution at about $30 billion. Discussions reportedly broke down over price, though sources said negotiations could resume later or another bidder could emerge. Revolution’s experimental therapies target lung, pancreatic and colon cancers.
